Biocryst Pharmaceuticals (BCRX) Inventory (2010 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Inventory came in at $6.0 million in Q1 2026, down 12.92% YoY from $6.9 million in Q1 2025, and up 10.87% on a QoQ basis from $5.4 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Inventory (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 15 years of Inventory data on file, last reported at $6.0 million in Q1 2026.
- Quarterly Inventory fell 12.92% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 12.92% YoY) and the FY2025 annual result came in at $5.4 million, down 33.25% from the prior year.
- Inventory climbed to $6.0 million in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $29.8 million in Q1 2024 to a low of $4.4 million in Q2 2024.
- A 5-year average of $16.8 million and a median of $16.4 million in 2022 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory surged 204.61% — and 2024, when it tumbled 83.54%.
- Tracing BCRX's Inventory over 5 years: stood at $27.5 million in 2022, then climbed by 4.18% to $28.7 million in 2023, then tumbled by 71.81% to $8.1 million in 2024, then slumped by 33.25% to $5.4 million in 2025, then gained by 10.87% to $6.0 million in 2026.
- The last three Inventory figures came in at $6.0 million (Q1 2026), $5.4 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.46 Bn | 2.11 Bn | 214.41 Mn | 6.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.06 Mn |
| Mar 31, 2026 | 5.99 Mn |
| Dec 31, 2025 | 5.40 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 8.09 Mn |
| Sep 30, 2024 | 7.56 Mn |
| Jun 30, 2024 | 4.45 Mn |
| Mar 31, 2024 | 29.78 Mn |
| Dec 31, 2023 | 28.68 Mn |
| Sep 30, 2023 | 29.63 Mn |
| Jun 30, 2023 | 27.03 Mn |
| Mar 31, 2023 | 27.47 Mn |
| Dec 31, 2022 | 27.53 Mn |
| Sep 30, 2022 | 27.02 Mn |
| Jun 30, 2022 | 23.38 Mn |
| Mar 31, 2022 | 16.40 Mn |
| Dec 31, 2021 | 15.79 Mn |
| Sep 30, 2021 | 13.66 Mn |